[
  {
    "ticker": "PEB",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968811",
    "id": "02968811",
    "pages": 10,
    "price_sensitive": true,
    "date": "20250714",
    "time": "0730",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrlhgrd1s0s7.pdf",
    "summary": "<h3><strong>Summary of Material Information (ASX Announcement - Pacific Edge; 14 July 2025)</strong></h3>\n<h4><strong>1. Capital Raising Details</strong></h4>\n<ul>\n<li><strong>Structure</strong>: Placement (completed) + Share Purchase Plan (SPP).  </li>\n<li><strong>Placement</strong>: AUD $16.1M raised (oversubscribed) at $0.10/share (18% premium to 20-day VWAP).  </li>\n<li><strong>SPP</strong>: Targeting AUD $5M (potential oversubscription) at same price; contingent on shareholder approval.  </li>\n<li><strong>Key Dates</strong>:  </li>\n<li><strong>Annual Meeting</strong>: 6 August 2025 (Auckland) for shareholder approval of placement and SPP.  </li>\n</ul>\n<h4><strong>2. Medicare Coverage &amp; Operational Impact</strong></h4>\n<ul>\n<li><strong>Medicare Reconsideration</strong>: Positive discussions with Novitas; potential to reopen coverage for <em>Triage</em> based on new evidence (STRATA study, AUA guideline inclusion).  </li>\n<li>Next meeting on 17 July for <em>Monitor</em> reconsideration.  </li>\n<li><strong>Test Volume Decline</strong>:  </li>\n<li><strong>US TLT</strong>: Down 11.9% QoQ to 5,717 tests (disruption from switch from <em>Detect</em> to <em>Triage</em>).  </li>\n<li><strong>Triage Adoption</strong>: 77% of US tests in June (vs. 22% in Q4 2025).  </li>\n<li><strong>APAC Growth</strong>: +8.8% QoQ to 1,183 tests.  </li>\n</ul>\n<h4><strong>3. Triage Plus Commercialization</strong></h4>\n<ul>\n<li><strong>Analytical Validation Published</strong>: Supports Medicare reconsideration; draft price set at <strong>US$1,018/test</strong> (vs. $760 for <em>Triage</em>).  </li>\n<li><strong>Clinical Evidence</strong>: <em>DRIVE</em> study submitted for peer review (final step pre-commercialization).  </li>\n</ul>\n<h4><strong>4. Liquidity &amp; Strategic Focus</strong></h4>\n<ul>\n<li>Capital raise extends cash runway by <strong>12+ months</strong> (non-Medicare operations).  </li>\n<li>Focus on regaining coverage, scaling <em>Triage Plus</em>, and payer contracts (e.g., Optum VA, Blue Cross).  </li>\n</ul>\n<hr />\n<p><strong>Note</strong>: Omitted routine updates (e.g., annual meeting logistics, director re-elections).</p>",
    "usage": {
      "prompt_tokens": 7214,
      "completion_tokens": 461,
      "total_tokens": 7675,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T21:38:15.813236"
  },
  {
    "ticker": "SNZ",
    "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02968810",
    "id": "02968810",
    "pages": 6,
    "price_sensitive": false,
    "date": "20250714",
    "time": "0730",
    "pdf_url": "https://announcements.asx.com.au/asxpdf/20250714/pdf/06lrlf7nq5f4mq.pdf",
    "summary": "<ul>\n<li><strong>Announcement Type</strong>: Application for quotation of new securities (employee incentive scheme issuance)  </li>\n<li><strong>Securities Issued</strong>: 192,360 ordinary fully paid shares (ASX: SNZ)  </li>\n<li><strong>Issue Date</strong>: 14/07/2025  </li>\n<li><strong>Issue Price</strong>: NZD 11.8757 per share  </li>\n<li><strong>Ranking</strong>: Equal to existing ordinary shares  </li>\n<li><strong>Key Management Personnel Issuances</strong>:  </li>\n<li>Scott Scoullar: 84 shares  </li>\n<li>Margaret Warrington: 84 shares  </li>\n<li><strong>Post-Issuance Capital</strong>:  </li>\n<li>Quoted ordinary shares: 241,123,378  </li>\n<li>Unquoted bonds/options: 375M bonds + 1.36M options  </li>\n</ul>\n<p><em>No material trading or capital structure impacts identified (routine employee equity issuance).</em></p>",
    "usage": {
      "prompt_tokens": 1489,
      "completion_tokens": 176,
      "total_tokens": 1665,
      "prompt_tokens_details": null
    },
    "model": "deepseek/deepseek-chat-v3-0324:free",
    "processed_at": "2025-07-13T21:38:03.103890"
  }
]